期刊文献+

易化的经皮冠脉介入治疗——急性心肌梗死治疗新策略 被引量:12

Facilitated Percutaneous Coronary Intervention—A New Strategy for Acute Myocardial Infarction
下载PDF
导出
摘要 急性心肌梗死再灌注治疗的方法主要包括溶栓和紧急经皮冠脉介入治疗,其中溶栓治疗简单易行,但再灌注不充分,并且再闭塞率高;而直接经皮冠脉介入治疗,可以恢复心外膜血管的血流,血管的开通率高,但是只有在有条件的医院才能进行,而对于急性心肌梗死来讲,血管开通的时间是最重要的,因此,人们试图通过将溶栓治疗和经皮冠脉介入治疗联合应用来发挥各自的优势,尽量减少缺陷来尽快恢复心脏血流供给,也就是采用易化经皮冠脉介入治疗的方法来治疗急性ST段抬高心肌梗死,从而获得梗死相关动脉更早的开通和更高的开通率。 Thrombolysis and primary percutaneous coronary intervention (PCI) are two major methods of reperfusion in acute myocardial infarction ( AMI ). However, thrombolysis therapy has a lower rate of patency of infarction-related artery ( IRA ) , and a higher rate of reinfarction, primary PCI has a higher rate of patency of IRA, but can only be performed in a few medical centres. Time is critical in cases of AMI. Doctors therefore want to combine thrombolysis with PCI in order to restore blood flow of IRA as soon as possible and at the same time, obtain the highest rate of patency of IRA.
出处 《心血管病学进展》 CAS 2007年第2期261-265,共5页 Advances in Cardiovascular Diseases
关键词 急性心肌梗死 经皮冠脉介入治疗 易化 acute myocardial infarction percutaneous coronary intervention facilitated
  • 相关文献

参考文献20

  • 1Boura JA,Grines CL.Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction:quantitative review of randomised trials[J].Lancet,2006,367(9510):579-588.
  • 2Bonnefoy E,Lapostolle F,Leizorovicz A,et al.Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction:A randomized study[J].Lancet,2002,360:525-829.
  • 3Steg PG,Bonnefoy E,Chabaud S,et al.Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty,data from the CAPTIM randomized clinical trial[J].Circulation,2003,108:2851-2856.
  • 4Cannon CP,Gibson CM,Lambrew CT,et al.Relationship of symptom onset to balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction[J].JAMA,2000,283:2941-2947.
  • 5Topol EJ,Califf RM,Kereiakes DJ,et al.Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial[J].J Am Coll Cardiol,1987,10(5 suppl B):65B-74B.
  • 6Rogers WJ,Baim DS,Gore JM,et al.Comparison of immediate invasive,delayed invasive,and conservative strategies after tissue-type plasminogen activator.Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase Ⅱ-A trial[J].Circulation,1990,81(5):1457-1476.
  • 7Ross AM,Coyne KS,Reiner JS,et al.A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction:the PACT trial.PACT investigators.Plasminogen-activator Angioplasty Compatibility Trial[J].J Am Coll Cardiol,1999,34(7):1954-1962.
  • 8Herrmann HC,Moliterno DJ,Ohman EM,et al.Facilitated of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction:results from the SPEED (GUSTO-4Pilot)Trial[J].J Am Coll Cardiol,2000,36:1489-1496.
  • 9Antman EM,Giugliano RP,Gibson RM,et al.Abciximab facilitates the rate and extent ot thrombolysis:results of the Thrombolysis In Myocardial Infarction(TIMI)14 trial[J].Circulation,1996,99:2720-2732.
  • 10Scheller B,Hennen B,Hammer B,et al.SIAM Ⅲ Study Group.Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction[J].J Am Coll Cardiol,2003,42(4):634-641.

二级参考文献9

  • 1Ross AM, Coyne KS, Reiner JS, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol, 1999,34:1954-1962.
  • 2Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Circulation, 1999,99:2729-2732.
  • 3De Lemos JA, Antman EM, Gibson CM, et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: observations from the TIMI 14 study. Circulation, 2000,101: 239-243.
  • 4Strategies for Patency Enhancement in the Emergency Department (SPEED) Investigators. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation, 2000,101:2788-2794.
  • 5Topol EJ, for the the GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein Ⅱb/Ⅲa inhibition: the GUSTO V randomised trial. Lancet, 2001,357:1905-1914.
  • 6Lincoff AM, Califf RM, van de Werf F, et al. for the GUSTO V Investigators. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy versus conventional fibrinolytic therapy for acute myocardial infarction: The GUSTO V randomized trial. JAMA, 2002,288:2130-2135.
  • 7Montalescot G, Barragan P, Wittenberg O, et al, for the ADMIRAL investigators. Platelet glycoprotein Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med, 2002,344:1895-1903.
  • 8Brener SJ, Zeymer U, Adgey AAJ, et al. Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the Integrilin and Low-Dose Thrombolysis in Acute Myocardial Infarction (INTRO AMI) Trial. J Am Coll Cardiol, 2002,39:377-386.
  • 9Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial: PRAGUE-2. Eur Heart J, 2003,24:94-104.

共引文献2

同被引文献47

引证文献12

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部